Dr Reddys Laboratories RDY
NYSE RDY
$14.82 -0.09 (-0.57%)
As of: Nov 9, 2026 · 10:19 AM EST

Dr Reddys Laboratories (RDY) Net Income (2009 - 2026)

Updated

Dr Reddys Laboratories (RDY) posted Net Income of $95.56 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 41.6% from $163.58 million a year earlier but up 108.1% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Net Income (2009 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Net Income at Dr Reddys Laboratories was $299.19 million, down 55.9% year-over-year; for FY2026 (ended Mar 31, 2026), it was $452 million, down 32.6% from FY2025.

  • Annual Net Income shows a five-year compound annual growth rate of 13.9% (FY2021 to FY2026).
  • In prior fiscal years, Dr Reddys Laboratories' Net Income was $671 million in FY2025 (+0.4%), $668 million in FY2024 (+21.9%), $548 million in FY2023 (+76.2%) and $311 million in FY2022 (+31.8%).
  • Quarterly Net Income has run from a low of $11.64 million in fiscal Q4 2022 to a high of $183.29 million in fiscal Q4 2025 over five years.
  • On a year-over-year basis, Net Income has declined in each of the last four quarters, with an average decline of 25.3% over the last eight quarters.
  • The strongest year-over-year quarter for Net Income in the past five years was fiscal Q4 2023, with growth of 902.7%; the weakest was fiscal Q4 2026, with a decline of 86.8%.
  • According to Business Quant data, Net Income for the three prior fiscal quarters was $45.93 million (Q1 2027), $24.12 million (Q4 2026) and $133.59 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,239.46 Bn 1,213.08 Bn 20.46 Bn 6.45 Bn
2 Johnson & Johnson 667.12 Bn 586.98 Bn 17.30 Bn 210.00 Mn
3 AbbVie 514.05 Bn 482.06 Bn 13.12 Bn 4.22 Bn
4 Merck 362.55 Bn 325.49 Bn 13.19 Bn 5.07 Bn
5 Novartis Ag 313.81 Bn 287.05 Bn - -
6 Astrazeneca 291.69 Bn 265.59 Bn 13.26 Bn 3.12 Bn
7 Amgen 247.31 Bn 198.96 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 208.37 Bn 183.48 Bn 6.73 Bn 2.43 Bn
9 Pfizer 165.98 Bn 113.34 Bn 12.56 Bn 3.25 Bn
10 Dr Reddys Laboratories 12.34 Bn 11.68 Bn 472.93 Mn 95.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 95.56 Mn
Jun 30, 2026 45.93 Mn
Mar 31, 2026 24.12 Mn
Dec 31, 2025 133.59 Mn
Sep 30, 2025 163.58 Mn
Jun 30, 2025 164.71 Mn
Mar 31, 2025 183.29 Mn
Dec 31, 2024 166.26 Mn
Sep 30, 2024 160.17 Mn
Jun 30, 2024 166.87 Mn
Mar 31, 2024 157.38 Mn
Dec 31, 2023 165.60 Mn
Sep 30, 2023 179.04 Mn
Jun 30, 2023 170.71 Mn
Mar 31, 2023 116.69 Mn
Dec 31, 2022 151.90 Mn
Sep 30, 2022 139.58 Mn
Jun 30, 2022 154.01 Mn
Mar 31, 2022 11.64 Mn
Dec 31, 2021 94.29 Mn
API Access

Dr Reddys Laboratories Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income&ticker=RDY&period=max&api_key=YOUR_API_KEY